• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征患儿的粪便钙卫蛋白总是正常的吗?

Is fecal calprotectin always normal in children with irritable bowel syndrome?

作者信息

Choi You Jin, Jeong Su Jin

机构信息

Department of Pediatrics, Inje University Ilsan Paik Hospital, Goyang, Korea.

Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.

出版信息

Intest Res. 2019 Oct;17(4):546-553. doi: 10.5217/ir.2019.00009. Epub 2019 Sep 4.

DOI:10.5217/ir.2019.00009
PMID:31467259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6821949/
Abstract

BACKGROUND/AIMS: Fecal calprotectin (FC) is a marker of intraluminal intestinal inflammation. Intestinal inflammation may contribute to the pathophysiology of irritable bowel syndrome (IBS). This study evaluated FC levels in children with IBS and differences in FC levels in children stratified by IBS subtype and healthy controls (HCs).

METHODS

A total of 157 children with IBS and 56 HCs aged 4-16 years (119 boys, 94 girls, mean age of 9.48 years) were included in this prospective study. Children with IBS were diagnosed using the Rome III criteria and classified into 4 subtypes: IBS with constipation (IBS-C, n=37), IBS with diarrhea (IBS-D, n=54), IBS with alternating constipation and diarrhea (IBS-M, n=49), and IBS unsubtyped (IBS-U, n=17); postinfectious IBS (PI-IBS) was also considered. The FC concentration in stool samples was analyzed using an enzyme-linked immunosorbent assay. All participants answered a questionnaire regarding several demographic and clinical characteristics.

RESULTS

Children with IBS had significantly higher levels of FC than the HCs (88.71 μg/g vs. 17.77 μg/g). Among the 4 IBS subtypes, the FC concentration was highest in children with IBS-D, followed by those with IBS-M, IBS-C, and IBS-U (169.94 μg/g vs. 45.04, 31.22, and 33.52 μg/g, respectively), and these differences were statistically significant. For PI-IBS, 90% of cases were in the IBS-D group.

CONCLUSIONS

The FC level was significantly higher in children with IBS than in HCs and differed depending on the IBS subtype, supporting the notion that IBS is a type of low-grade bowel inflammation.

摘要

背景/目的:粪便钙卫蛋白(FC)是肠腔内肠道炎症的标志物。肠道炎症可能参与肠易激综合征(IBS)的病理生理过程。本研究评估了IBS患儿的FC水平,以及按IBS亚型分层的患儿与健康对照(HC)之间FC水平的差异。

方法

本前瞻性研究纳入了157例4 - 16岁的IBS患儿和56例HC(119例男孩,94例女孩,平均年龄9.48岁)。IBS患儿根据罗马III标准进行诊断,并分为4个亚型:便秘型IBS(IBS - C,n = 37)、腹泻型IBS(IBS - D,n = 54)、混合型IBS(IBS - M,n = 49)和未分型IBS(IBS - U,n = 17);感染后IBS(PI - IBS)也纳入考虑。采用酶联免疫吸附测定法分析粪便样本中的FC浓度。所有参与者均回答了一份关于若干人口统计学和临床特征的问卷。

结果

IBS患儿的FC水平显著高于HC(88.71μg/g对17.77μg/g)。在4种IBS亚型中,FC浓度在IBS - D患儿中最高,其次是IBS - M、IBS - C和IBS - U患儿(分别为169.94μg/g对45.04、31.22和33.

52μg/g),这些差异具有统计学意义。对于PI - IBS,90%的病例在IBS - D组。

结论

IBS患儿的FC水平显著高于HC,且因IBS亚型而异,支持IBS是一种低度肠道炎症的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a1c/6821949/6d7b004ef000/ir-2019-00009f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a1c/6821949/703281f9a872/ir-2019-00009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a1c/6821949/6d7b004ef000/ir-2019-00009f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a1c/6821949/703281f9a872/ir-2019-00009f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a1c/6821949/6d7b004ef000/ir-2019-00009f2.jpg

相似文献

1
Is fecal calprotectin always normal in children with irritable bowel syndrome?肠易激综合征患儿的粪便钙卫蛋白总是正常的吗?
Intest Res. 2019 Oct;17(4):546-553. doi: 10.5217/ir.2019.00009. Epub 2019 Sep 4.
2
Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome.粪便钙卫蛋白:一种用于显微镜下结肠炎和肠易激综合征临床鉴别的标志物。
Clin Exp Gastroenterol. 2016 Apr 21;9:97-103. doi: 10.2147/CEG.S97701. eCollection 2016.
3
Faecal calprotectin levels after rifaximin treatment in patients with irritable bowel syndrome with diarrhoea: A single-center prospective study.利福昔明治疗腹泻型肠易激综合征患者后粪便钙卫蛋白水平:一项单中心前瞻性研究。
Arab J Gastroenterol. 2020 Dec;21(4):273-277. doi: 10.1016/j.ajg.2020.08.003. Epub 2020 Sep 12.
4
Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.炎症性肠病患者出现真正的肠易激综合征样症状对心理健康和生活质量的负面影响。
Clin Gastroenterol Hepatol. 2017 Mar;15(3):376-384.e5. doi: 10.1016/j.cgh.2016.05.012. Epub 2016 May 14.
5
Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.结肠黏膜微生物群与肠易激综合征患者的排便习惯亚型和腹痛有关。
Am J Physiol Gastrointest Liver Physiol. 2022 Aug 1;323(2):G134-G143. doi: 10.1152/ajpgi.00352.2021. Epub 2022 Jun 21.
6
Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.罗马 III 标准下的肠易激综合征亚型:一项多中心研究。
J Gastroenterol Hepatol. 2012 Apr;27(4):760-5. doi: 10.1111/j.1440-1746.2011.06930.x.
7
Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study.感染后及非感染后肠易激综合征的半定量粪便钙卫蛋白检测:横断面研究
Sao Paulo Med J. 2015 Jul-Aug;133(4):343-9. doi: 10.1590/1516-3180.2014.8000815. Epub 2014 Dec 19.
8
Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.腹泻型肠易激综合征患者的疾病特异性生活质量低于便秘型肠易激综合征患者。
World J Gastroenterol. 2015 Jul 14;21(26):8103-9. doi: 10.3748/wjg.v21.i26.8103.
9
Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.罗马 III 功能性便秘和便秘型肠易激综合征是一种具有相似特征的疾病谱,受 5-羟色胺调节。
Gastroenterology. 2013 Oct;145(4):749-57; quiz e13-4. doi: 10.1053/j.gastro.2013.07.014. Epub 2013 Jul 19.
10
Peroxiredoxin 1 as an inflammatory marker in diarrhea-predominant and postinfectious irritable bowel syndrome.过氧化物酶 1 作为腹泻为主型和感染后肠易激综合征的炎症标志物。
Neurogastroenterol Motil. 2020 Feb;32(2):e13741. doi: 10.1111/nmo.13741. Epub 2019 Oct 15.

引用本文的文献

1
The Interplay Between Immunological Status and Gut Microbial Dysbiosis in the Development of the Symptoms of Irritable Bowel Syndrome: A Systematic Review with Meta-Analysis.免疫状态与肠道微生物群失调在肠易激综合征症状发展中的相互作用:一项系统评价与荟萃分析
Dig Dis Sci. 2025 Sep 3. doi: 10.1007/s10620-025-09360-w.
2
Markers of Intestinal Permeability and Inflammation in Enterally Fed Children with Cerebral Palsy.脑性瘫痪患儿肠内喂养时肠道通透性和炎症标志物的变化
Nutrients. 2024 Jul 27;16(15):2447. doi: 10.3390/nu16152447.
3
Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study.

本文引用的文献

1
Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.钙卫蛋白水平能否识别肠易激综合征患者中的一个亚组?一项前瞻性研究的结果。
United European Gastroenterol J. 2017 Mar;5(2):261-269. doi: 10.1177/2050640616650062. Epub 2016 Jun 23.
2
Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place.肠易激综合征与炎症性肠病重叠综合征:拼图碎片正在拼凑完整。
Intest Res. 2016 Oct;14(4):297-304. doi: 10.5217/ir.2016.14.4.297. Epub 2016 Oct 17.
3
Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome.
评估酪蛋白糖巨肽在成人肠易激综合征管理中的潜力:一项初步研究。
Nutrients. 2023 Sep 27;15(19):4174. doi: 10.3390/nu15194174.
4
The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome.牛κ-酪蛋白糖巨肽在调节肠易激综合征微生物群和炎症反应中的作用
Nutrients. 2023 Sep 15;15(18):3991. doi: 10.3390/nu15183991.
5
Infantile Colic and the Subsequent Development of the Irritable Bowel Syndrome.婴儿腹绞痛与肠易激综合征的后续发展
J Neurogastroenterol Motil. 2022 Oct 30;28(4):618-629. doi: 10.5056/jnm21181.
6
An Update on the Assessment and Management of Pediatric Abdominal Pain.小儿腹痛评估与管理的最新进展
Pediatric Health Med Ther. 2021 Aug 6;12:373-393. doi: 10.2147/PHMT.S287719. eCollection 2021.
7
Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis.越来越多的证据表明,肠易激综合征和功能性胃肠疾病具有微生物发病机制。
Front Cell Infect Microbiol. 2020 Sep 9;10:468. doi: 10.3389/fcimb.2020.00468. eCollection 2020.
8
Irritable bowel syndrome in Indonesian adolescents.印度尼西亚青少年肠易激综合征。
J Pediatr (Rio J). 2021 Mar-Apr;97(2):197-203. doi: 10.1016/j.jped.2020.02.001. Epub 2020 Mar 8.
粪便钙卫蛋白:一种用于显微镜下结肠炎和肠易激综合征临床鉴别的标志物。
Clin Exp Gastroenterol. 2016 Apr 21;9:97-103. doi: 10.2147/CEG.S97701. eCollection 2016.
4
Value of Fecal Calprotectin as a Biomarker for Juvenile Polyps in Children Investigated With Colonoscopy.粪便钙卫蛋白作为结肠镜检查的儿童青少年息肉生物标志物的价值
J Pediatr Gastroenterol Nutr. 2016 Jan;62(1):43-6. doi: 10.1097/MPG.0000000000000893.
5
Epidemiology of irritable bowel syndrome in children and adolescents in Asia.亚洲儿童和青少年肠易激综合征的流行病学
J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):792-8. doi: 10.1097/MPG.0000000000000714.
6
Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.粪便钙卫蛋白在炎症性肠病及其他疾病中的应用:一篇迷你综述。
Can J Gastroenterol Hepatol. 2015 Apr;29(3):157-63. doi: 10.1155/2015/950286.
7
A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.一项关于 C 反应蛋白、红细胞沉降率、粪便钙卫蛋白和乳铁蛋白在排除 IBS 成人炎症性肠病中的效用的荟萃分析。
Am J Gastroenterol. 2015 Mar;110(3):444-54. doi: 10.1038/ajg.2015.6. Epub 2015 Mar 3.
8
Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine.肠易激综合征:发病机制、诊断、治疗及循证医学
World J Gastroenterol. 2014 Jun 14;20(22):6759-73. doi: 10.3748/wjg.v20.i22.6759.
9
Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease.六种不同钙卫蛋白检测方法用于评估炎症性肠病的比较。
United European Gastroenterol J. 2014 Feb;2(1):30-7. doi: 10.1177/2050640613518201.
10
Subtypes of irritable bowel syndrome in children and adolescents.儿童和青少年肠易激综合征的亚型
Clin Gastroenterol Hepatol. 2014 Sep;12(9):1468-73. doi: 10.1016/j.cgh.2014.01.031. Epub 2014 Jan 29.